Use of electroconvulsive therapy for schizophrenia with comorbid Marfan syndrome.
The study of psychiatric disorders co-occurring with rare genetic syndromes has important therapeutic and pathophysiological implications. Electroconvulsive therapy (ECT) in schizophrenia with comorbid Marfan syndrome is challenging in view of multiorgan involvement. We report successful use of ECT in a patient who presented to us with catatonia and Marfan syndrome. The report highlights the importance of careful evaluation of patients with schizophrenia and Marfan syndrome before ECT in liaison with other specialties.
Rao
Naren P
NP
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India. docnaren@gmail.com
Loganathan
Santosh
S
Prakash
Om
O
Varghese
Mathew
M
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002389:Catatonia / Q000150:complications / Q000523:psychology / Q000628:therapy; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008382:Marfan Syndrome / Q000150:complications*; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000150:complications* / Q000628:therapy*; D012565:Schizophrenic Psychology; D014282:Trihexyphenidyl / Q000627:therapeutic use
D014150:Antipsychotic Agents; D018727:Muscarinic Antagonists; D014282:Trihexyphenidyl